Related Experiment Video
Updated: Aug 14, 2026

Biaxial Mechanical Characterizations of Atrioventricular Heart Valves
Published on: April 9, 2019
Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves
Scott A LeMaire1, Xinwen Wang, Jonathan A Wilks
1Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine and The Methodist DeBakey Heart Center, Houston, Texas, USA. slemaire@bcm.tmc.edu
Background:
Abnormal matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) expression contributes to the development of abdominal aortic aneurysms. Recent data suggest that MMP-2 and MMP-9 may also play a role in thoracic aortic disease. We sought to determine (1) whether ascending aortic aneurysms are associated with increased MMP expression and (2) whether aortic inflammation and MMP expression differ between patients with congenital bicuspid aortic valves (BAVs) and those with trileaflet aortic valves (TAVs).
Materials And Methods:
Samples of ascending aortic aneurysms were obtained from 29 patients; 14 patients had BAVs and 15 had TAVs. Control ascending aorta was obtained from 14 organ donors or heart transplant recipients. Aortic histology and immunohistochemistry were performed to evaluate elastin degradation, inflammatory changes, and MMP-2 and MMP-9 expression. Aortic levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 were measured using ELISA.
Results:
Aneurysms in the TAV patients exhibited marked inflammation, high CD68 expression, diminished elastin content, increased MMP-9 expression, and normal MMP-2 levels. In contrast, BAV aneurysms were characterized by a relative lack of inflammation, preservation of elastin content, normal MMP-9 levels, and elevated MMP-2 expression. TIMP-1 and TIMP-2 levels were not significantly different among the three groups.
Conclusions:
Ascending aortic aneurysms exhibited increased MMP expression. The pattern of MMP expression and the degree of inflammation, however, differed between aneurysms associated with BAVs and those with TAVs. Variations in the molecular mechanisms underlying different types of thoracic aortic aneurysms warrant further investigation.
Insights
Ascending aortic aneurysms show altered matrix metalloproteinase (MMP) expression. Differences in MMP patterns and inflammation exist between bicuspid (BAV) and trileaflet (TAV) aortic valve aneurysms.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Aortic Disease
Background:
- Abnormal matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) expression is implicated in abdominal aortic aneurysms.
- MMP-2 and MMP-9 may play a role in thoracic aortic disease.
Purpose of the Study:
- To determine if ascending aortic aneurysms are associated with increased MMP expression.
- To investigate differences in aortic inflammation and MMP expression between congenital bicuspid aortic valves (BAVs) and trileaflet aortic valves (TAVs).
Main Methods:
- Ascending aortic aneurysm samples from 29 patients (14 BAV, 15 TAV) and 14 controls were analyzed.
- Histology, immunohistochemistry, and ELISA were used to assess elastin degradation, inflammation, and MMP/TIMP levels.
Main Results:
- TAV aneurysms showed inflammation, high CD68, reduced elastin, and increased MMP-9.
- BAV aneurysms had less inflammation, preserved elastin, normal MMP-9, and elevated MMP-2.
- TIMP-1 and TIMP-2 levels were similar across groups.
Conclusions:
- Ascending aortic aneurysms are associated with increased MMP expression.
- Distinct patterns of MMP expression and inflammation differentiate BAV and TAV aneurysms.
- Further research is needed to understand the molecular mechanisms of different thoracic aortic aneurysms.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care

